Muscle invasive bladder cancer: A single sample patient assay to predict molecular subtypes and benefit of neoadjuvant chemotherapyRoland Seiler, P. Black, Brian Winters et al.|European Urology Supplements|2017Cited by 1
Biological characterization of cisplatin-resistant bladder cancer: Implications for second-line treatments?Roland Seiler, P. Black, Ewan A. Gibb et al.|European Urology Supplements|2018Cited by 0